Perfluoroalkyl substances and preterm birth

Anne M Mullin¹, Abby F Fleisch^{2

3}, Clementina Mesaros^{4

5}, Rachel Ledyard⁶, Michele R Hacker^{7

8}, Heather H Burris^{9

10

11

12}

Affiliations

¹ Tufts University School of Medicine, Boston, MA, USA.
² Center for Interdisciplinary Population & Health Research, Maine Health Institute for Research, Westbrook, ME, USA.
³ Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland, ME, USA.
⁴ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁶ Division of Neonatology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁸ Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, USA.
⁹ Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.
¹⁰ Division of Neonatology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.
¹¹ Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.
¹² Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.

Anne M Mullin et al. J Perinatol. 2025 Apr.

. 2025 Apr;45(4):539-541.

doi: 10.1038/s41372-025-02231-2. Epub 2025 Feb 18.

Anne M Mullin¹, Abby F Fleisch^{2

3}, Clementina Mesaros^{4

5}, Rachel Ledyard⁶, Michele R Hacker^{7

8}, Heather H Burris^{9

10

11

12}

¹ Tufts University School of Medicine, Boston, MA, USA.
² Center for Interdisciplinary Population & Health Research, Maine Health Institute for Research, Westbrook, ME, USA.
³ Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland, ME, USA.
⁴ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁶ Division of Neonatology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁸ Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, USA.
⁹ Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.
¹⁰ Division of Neonatology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.
¹¹ Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.
¹² Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. burrish@chop.edu.

No abstract available

Conflict of interest statement

Competing interests: The authors declare no competing interests.

1. Siwakoti RC, Cathey A, Ferguson KK, Hao W, Cantonwine DE, Mukherjee B et al. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006–2008. Environ Res 2023; 237: 116967. - PMC - PubMed
1. Gui S-Y, Chen Y-N, Wu K-J, Liu W, Wang W-J, Liang H-R et al. Association Between Exposure to Per- and Polyfluoroalkyl Substances and Birth Outcomes: A Systematic Review and Meta-Analysis. Front Public Health 2022; 10.https://www.frontiersin.org/articles/10.3389/fpubh.2022.855348 (accessed 12 Oct2023). - DOI - PMC - PubMed
1. Burris HH, Gerson KD, Woodward A, Redhunt AM, Ledyard R, Brennan K et al. Cervical microRNA expression and spontaneous preterm birth. Am J Obstet Gynecol MFM 2023; 5: 100783. - PMC - PubMed
1. Frigerio G, Cafagna S, Polledri E, Mercadante R, Fustinoni S. Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4. Anal Bioanal Chem 2022; 414: 1259–1278. - PMC - PubMed
1. Preston EV, Hivert M-F, Fleisch AF, Calafat AM, Sagiv SK, Perng W et al. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort. Environ Int 2022; 165: 107335. - PMC - PubMed